Kaunzner, Ulrike W.

Publications

Sort by

Co-Author Network

selected publications

Impact of paramagnetic rim lesions on disability and race in multiple sclerosis: mediation analysis. Annals of clinical and translational neurology. 2024 Academic Article GET IT
The use of modafinil for the treatment of fatigue in multiple sclerosis: A systematic review and meta-analysis of controlled clinical trials. Brain and behavior. 2024 Review GET IT
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis. JAMA neurology. 2024 Academic Article GET IT
The sequence of regional structural disconnectivity due to multiple sclerosis lesions. Brain communications. 2023 Academic Article GET IT
FLAIR-Hyperintense Lesions in Anti-MOG-Associated Encephalitis With Seizures (FLAMES). The Neurohospitalist. 2023 Academic Article GET IT
No Evidence of Disease Activity (NEDA) as a Clinical Assessment Tool for Multiple Sclerosis: Clinician and Patient Perspectives [Narrative Review]. Neurology and therapy. 2023 Review GET IT
Epsilon toxin-producing Clostridium perfringens colonize the MS gut and epsilon toxin overcomes immune privilege. The Journal of clinical investigation. 2023 Academic Article GET IT
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity. Proceedings of the National Academy of Sciences of the United States of America. 2023 Academic Article GET IT
Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis. Scientific reports. 2022 Academic Article GET IT
Quantitative susceptibility mapping versus phase imaging to identify multiple sclerosis iron rim lesions with demyelination. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2022 Academic Article GET IT
Structural disconnectivity from paramagnetic rim lesions is related to disability in multiple sclerosis. Brain and behavior. 2021 Academic Article GET IT
Lesion features on magnetic resonance imaging discriminate multiple sclerosis patients. European journal of neurology. 2021 Academic Article GET IT
QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions. Annals of clinical and translational neurology. 2021 Academic Article GET IT
Times cited: 43
A Multi-Ligand Imaging Study Exploring GABAergic Receptor Expression and Inflammation in Multiple Sclerosis. Molecular imaging and biology. 2020 Academic Article GET IT
Impact of Lesion Location on Longitudinal Myelin Water Fraction Change in Chronic Multiple Sclerosis Lesions. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 2020 Academic Article GET IT
Times cited: 9
Black African and Latino/a identity correlates with increased plasmablasts in MS. Neurology(R) neuroimmunology & neuroinflammation. 2019 Academic Article GET IT
Times cited: 15
Quantitative Susceptibility Mapping of Time-Dependent Susceptibility Changes in Multiple Sclerosis Lesions. AJNR. American journal of neuroradiology. 2019 Academic Article GET IT
Times cited: 47
Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions. Brain : a journal of neurology. 2019 Academic Article GET IT
Times cited: 138
Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195. PloS one. 2018 Academic Article GET IT
Times cited: 10
Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS. Journal of neurology. 2018 Academic Article GET IT
Times cited: 1
Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). 2017 Article GET IT
Times cited: 1
MRI in the assessment and monitoring of multiple sclerosis: an update on best practice. Therapeutic advances in neurological disorders. 2017 Information Resource GET IT
Times cited: 87
Defining Disease Activity and Response to Therapy in MS. Current treatment options in neurology. 2017 Information Resource GET IT
Times cited: 9
Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation. Multiple sclerosis and related disorders. 2017 Academic Article GET IT
Times cited: 17
Immediate transient thrombocytopenia at the time of alemtuzumab infusion in multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). 2017 Academic Article GET IT
Times cited: 7
Rapidly progressive bilateral optic nerve and retinal infarctions due to rhinocerebral mucormycosis and pseudoephedrine use. 2016 GET IT
Times cited: 2
A study of patients with aggressive multiple sclerosis at disease onset. Neuropsychiatric disease and treatment. 2016 Academic Article GET IT
Times cited: 10
Diagnosing RCVS Without the CV: The Evolution of Reversible Cerebral Vasoconstriction Syndrome. The Neurohospitalist. 2015 Academic Article GET IT
Pituitary dendritic cells communicate immune pathogenic signals. Brain, behavior, and immunity. 2015 Academic Article GET IT
Times cited: 16
Delayed status epilepticus due to bupropion and lamotrigine overdose. Eastern Journal of Medicine. 2013 Article
Accumulation of resident and peripheral dendritic cells in the aging CNS. Neurobiology of aging. 2010 Academic Article GET IT
Times cited: 34
Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain, behavior, and immunity. 2009 Academic Article GET IT
Times cited: 119
Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells. Proceedings of the National Academy of Sciences of the United States of America. 2009 Academic Article GET IT
Times cited: 68
Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus. Histochemistry and cell biology. 2008 Academic Article GET IT
Times cited: 26
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. The Journal of comparative neurology. 2008 Academic Article GET IT
Times cited: 155

more ...

less ...

Background

education and training

Ph.D., Friedrich Schiller University (Germany) 2008
M.D., Friedrich Schiller University Faculty of Medicine (Germany) 2006

Contact

full name

Ulrike W. Kaunzner

primary email

uwk9002@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Ulrike W. Kaunzner Assistant Professor of Neurology

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage